Published in Front Cell Infect Microbiol on June 12, 2012
Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania. Nat Med (2013) 1.46
Leishmania donovani infection causes distinct epigenetic DNA methylation changes in host macrophages. PLoS Pathog (2014) 0.92
Immune regulation during chronic visceral leishmaniasis. PLoS Negl Trop Dis (2014) 0.88
Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice. Infect Immun (2015) 0.82
Characterization of the early inflammatory infiltrate at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites. PLoS Negl Trop Dis (2014) 0.82
Autophagic digestion of Leishmania major by host macrophages is associated with differential expression of BNIP3, CTSE, and the miRNAs miR-101c, miR-129, and miR-210. Parasit Vectors (2015) 0.81
The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis. Front Immunol (2016) 0.79
Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit Vectors (2016) 0.78
Post-Genomics and Vaccine Improvement for Leishmania. Front Microbiol (2016) 0.78
Toll-Like Receptor 9 Signaling in Dendritic Cells Regulates Neutrophil Recruitment to Inflammatory Foci following Leishmania infantum Infection. Infect Immun (2015) 0.78
Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation. PLoS One (2015) 0.78
Leishmania major Promastigotes Evade LC3-Associated Phagocytosis through the Action of GP63. PLoS Pathog (2016) 0.78
Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach. EURASIP J Bioinform Syst Biol (2015) 0.77
Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids. Front Immunol (2016) 0.76
Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules. Front Immunol (2016) 0.76
Atenolol Reduces Leishmania major-Induced Hyperalgesia and TNF-α Without Affecting IL-1β or Keratinocyte Derived Chemokines (KC). Front Pharmacol (2016) 0.76
Toll-Like Receptor 2 Is Required for Inflammatory Process Development during Leishmania infantum Infection. Front Microbiol (2017) 0.75
Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts. Proc Natl Acad Sci U S A (2017) 0.75
Leishmania infantum and Leishmania braziliensis: Differences and Similarities to Evade the Innate Immune System. Front Immunol (2016) 0.75
Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis. PLoS Negl Trop Dis (2016) 0.75
The site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular matrix in the dermis. Parasit Vectors (2016) 0.75
Identification and Characterization of miRNAs in Response to Leishmania donovani Infection: Delineation of Their Roles in Macrophage Dysfunction. Front Microbiol (2017) 0.75
The enemy within: Targeting host-parasite interaction for antileishmanial drug discovery. PLoS Negl Trop Dis (2017) 0.75
The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol (2017) 0.75
Modeling Immune Response to Leishmania Species Indicates Adenosine As an Important Inhibitor of Th-Cell Activation. Front Cell Infect Microbiol (2017) 0.75
The Role of BAFF System Molecules in Host Response to Pathogens. Clin Microbiol Rev (2017) 0.75
Dependency of B-1 Cells in the Maintenance of Splenic Interleukin-10 Producing Cells and Impairment of Macrophage Resistance in Visceral Leishmaniasis. Front Microbiol (2017) 0.75
Minimally invasive microbiopsies: a novel sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani. Int J Parasitol (2017) 0.75
IN VIVO AND IN VITRO ANTILEISHMANIAL EFFECTS OF METHANOLIC EXTRACT FROM BARK OF BURSERA APTERA. Afr J Tradit Complement Altern Med (2017) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
The MAPK signaling cascade. FASEB J (1995) 10.81
Mechanisms of phagocytosis in macrophages. Annu Rev Immunol (1999) 9.66
Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol (2005) 9.27
TLR signaling pathways. Semin Immunol (2004) 9.08
A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol (2008) 6.78
In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science (2008) 5.09
Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity (2007) 4.65
Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis (2008) 3.27
The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol (2001) 3.21
Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat Med (2007) 2.98
A role for insect galectins in parasite survival. Cell (2004) 2.72
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med (2005) 2.50
Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol (2004) 2.50
Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev (2005) 2.33
Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med (1998) 2.30
Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med (1996) 2.19
Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J (2005) 2.16
Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J Biol Chem (1991) 1.99
The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function. Mol Biochem Parasitol (2003) 1.93
TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J Immunol (2009) 1.91
Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog (2008) 1.90
Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol (1998) 1.89
Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol (1993) 1.88
MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol (2003) 1.82
Leishmaniasis reservoirs and their significance in control. Clin Dermatol (1997) 1.80
Macrophage interactions with neutrophils regulate Leishmania major infection. J Immunol (2004) 1.67
Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect Immun (2004) 1.65
CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol (2004) 1.61
Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200. Cell Host Microbe (2011) 1.59
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect Immun (1995) 1.54
Glycoconjugates in Leishmania infectivity. Biochim Biophys Acta (1999) 1.53
The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. Trends Microbiol (1998) 1.52
Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med (2011) 1.49
Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J Immunol (2004) 1.47
TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol (2007) 1.46
Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol (2002) 1.44
Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology (1990) 1.44
Invasion and intracellular survival by protozoan parasites. Immunol Rev (2011) 1.43
Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today (1994) 1.42
Modulation of dendritic cell function by Leishmania parasites. J Immunol (2008) 1.40
MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. J Exp Med (2004) 1.40
Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infect Immun (2002) 1.39
The Leishmania-macrophage interaction: a metabolic perspective. Cell Microbiol (2007) 1.37
Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase. J Immunol (2007) 1.35
Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. Sci Signal (2009) 1.32
Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect Immun (2006) 1.29
Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun (1999) 1.27
Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur J Immunol (1999) 1.27
Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc Natl Acad Sci U S A (1992) 1.26
The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Exp Parasitol (1991) 1.25
Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur J Immunol (2000) 1.23
The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J Biol Chem (2008) 1.22
Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. J Immunol (1990) 1.22
Specific recognition of Leishmania major poly-beta-galactosyl epitopes by galectin-9: possible implication of galectin-9 in interaction between L. major and host cells. J Biol Chem (2003) 1.20
Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol Immunol (2008) 1.20
IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol (2000) 1.18
Arginase I induction during Leishmania major infection mediates the development of disease. Infect Immun (2005) 1.15
Immunomodulatory properties of a phosphorylcholine-containing secreted filarial glycoprotein. Parasite Immunol (1999) 1.14
Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population. J Immunol (1996) 1.14
Host cell signalling and leishmania mechanisms of evasion. J Trop Med (2011) 1.13
The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis. Cell Microbiol (2009) 1.13
Leishmania parasites and their ploys to disrupt macrophage activation. Curr Opin Hematol (2000) 1.13
Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis. Cell Microbiol (2000) 1.12
Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology (2005) 1.10
Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils. Effects on cytosolic calcium release and superoxide production. J Immunol (1993) 1.06
Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. Eur J Immunol (1996) 1.05
Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein. Mol Biochem Parasitol (1994) 1.04
Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes. Infect Immun (2004) 1.02
Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major: inverse relationship to interleukin-12 production. Infect Immun (2002) 1.02
The role of protein kinase C in the induction of nitric oxide synthesis by murine macrophages. Biochem Biophys Res Commun (1992) 1.02
Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis. J Immunol (2009) 1.02
Leishmania major surface protease Gp63 interferes with the function of human monocytes and neutrophils in vitro. APMIS (1994) 0.97
Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK. Am J Pathol (2009) 0.96
A novel role for Stat1 in phagosome acidification and natural host resistance to intracellular infection by Leishmania major. PLoS Pathog (2009) 0.95
Role of protein kinase C-alpha in the control of infection by intracellular pathogens in macrophages. J Immunol (1999) 0.94
Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defense. Adv Exp Med Biol (2000) 0.92
Childhood visceral leishmaniasis. Indian J Med Res (2006) 0.92
Exploitation of the complement system by Leishmania promastigotes. Parasitol Today (1996) 0.91
Survival strategies of Leishmania donovani in mammalian host macrophages. Res Immunol (1999) 0.91
Critical role of dendritic cells in determining the Th1/Th2 balance upon Leishmania major infection. Int Immunol (2008) 0.89
Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions. Infect Immun (2009) 0.89
Specificity in signal transduction among glycosylphosphatidylinositols of Plasmodium falciparum, Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. Parasite Immunol (1999) 0.83
Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase. Mol Biochem Parasitol (2005) 0.82
Differential sensitivity of C57BL/6 (M-1) and BALB/c (M-2) macrophages to the stimuli of IFN-gamma/LPS for the production of NO: correlation with iNOS mRNA and protein expression. J Interferon Cytokine Res (2006) 0.82
Increased interleukin 4 (IL-4) receptor expression and IL-4-induced decrease in IL-12 production by Langerhans cells infected with Leishmania major. Infect Immun (2002) 0.80
The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J Immunol (2009) 1.12
Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis. J Immunol (2009) 1.02
Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol (2002) 1.00
The p110 delta isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets. J Immunol (2010) 0.96
Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process. Proc Natl Acad Sci U S A (2009) 0.94
Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion. J Immunol (2013) 0.94
LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major. J Immunol (2007) 0.93
Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY): in vivo evaluation in a pig model of enteric colibacillosis. Vet Immunol Immunopathol (2008) 0.91
Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions. Infect Immun (2009) 0.89
Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice. Infect Immun (2006) 0.89
CD4+CD25+ regulatory T cells attenuate lipopolysaccharide-induced systemic inflammatory responses and promotes survival in murine Escherichia coli infection. Shock (2013) 0.88
Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature. Immunotherapy (2009) 0.86
Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection. PLoS One (2012) 0.86
Altered proinflammatory cytokine production and enhanced resistance to Trypanosoma congolense infection in lymphotoxin beta-deficient mice. J Infect Dis (2009) 0.84
Regulatory T cells enhance susceptibility to experimental Trypanosoma congolense infection independent of mouse genetic background. PLoS Negl Trop Dis (2012) 0.82
Interleukin-17-mediated control of parasitemia in experimental Trypanosoma congolense infection in mice. Infect Immun (2010) 0.82
Lymphotoxin alpha beta 2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in mice. J Immunol (2007) 0.82
Deficiency of prolactin-inducible protein leads to impaired Th1 immune response and susceptibility to Leishmania major in mice. Eur J Immunol (2015) 0.79
Enhancement of IL-10 bioactivity using an IL-10 peptide-based vaccine exacerbates Leishmania major infection and improves airway inflammation in mice. Vaccine (2009) 0.79
Molecular regulation of Trypanosoma congolense-induced nitric oxide production in macrophages. PLoS One (2013) 0.79
Deficiency of Leishmania phosphoglycans influences the magnitude but does not affect the quality of secondary (memory) anti-Leishmania immunity. PLoS One (2013) 0.77
In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine. J Innate Immun (2016) 0.77
Immunity to visceral leishmaniasis: implications for immunotherapy. Future Microbiol (2014) 0.77